𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Risk and Benefit of Antibody Induction Therapy in Combination With Tacrolimus Immunosuppression After Liver Transplantation

✍ Scribed by J. Klupp; W.O. Bechstein; J. Pratschke; S.G. Tullius; A. Gebhard; H. Lobeck; J.M. Langrehr; R. Neuhaus; P. Neuhaus


Book ID
117236155
Publisher
Elsevier Science
Year
1998
Tongue
English
Weight
156 KB
Volume
30
Category
Article
ISSN
0041-1345

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Interleukin-2 receptor antibody (basilix
✍ Chi Leung Liu; Sheung Tat Fan; Chung Mau Lo; See Ching Chan; Irene O. Ng; Ching πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 82 KB

A prospective evaluation was performed to study the potential benefits of the use of interleukin-2 receptor antibody (IL-2Rab) in the induction therapy with early elimination of steroid and reduction of tacrolimus dosage in liver transplant recipients among whom 94% had chronic hepatitis B infection